Capital Advisors Ltd. LLC Buys 228 Shares of CVS Health Co. (NYSE:CVS)

Capital Advisors Ltd. LLC grew its stake in CVS Health Co. (NYSE:CVS) by 29.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,006 shares of the pharmacy operator’s stock after acquiring an additional 228 shares during the period. Capital Advisors Ltd. LLC’s holdings in CVS Health were worth $59,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of CVS. Riverpoint Wealth Management Holdings LLC purchased a new position in shares of CVS Health during the fourth quarter valued at $218,000. Canoe Financial LP boosted its stake in shares of CVS Health by 95.1% during the fourth quarter. Canoe Financial LP now owns 1,762,629 shares of the pharmacy operator’s stock valued at $139,177,000 after purchasing an additional 859,134 shares in the last quarter. Steph & Co. increased its holdings in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 288 shares during the period. Forum Financial Management LP raised its stake in CVS Health by 19.4% in the fourth quarter. Forum Financial Management LP now owns 17,856 shares of the pharmacy operator’s stock worth $1,410,000 after buying an additional 2,901 shares in the last quarter. Finally, Douglas Lane & Associates LLC boosted its position in CVS Health by 1.6% during the 1st quarter. Douglas Lane & Associates LLC now owns 1,084,256 shares of the pharmacy operator’s stock valued at $86,480,000 after acquiring an additional 16,840 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on CVS shares. Truist Financial reiterated a “buy” rating and issued a $66.00 target price (down previously from $90.00) on shares of CVS Health in a research note on Thursday, May 2nd. Evercore ISI cut their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a report on Thursday, August 8th. Bank of America decreased their price objective on CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. The Goldman Sachs Group lowered their price target on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft cut their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Eleven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $73.24.

CVS Health Stock Up 0.1 %

Shares of CVS opened at $58.83 on Monday. The stock has a market capitalization of $73.85 billion, a price-to-earnings ratio of 10.33, a PEG ratio of 0.57 and a beta of 0.52. The stock has a 50 day moving average price of $58.86 and a 200 day moving average price of $65.01. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.21 earnings per share. Equities research analysts forecast that CVS Health Co. will post 7 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.52%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s payout ratio is currently 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.